NCT00713921 is a EARLY_PHASE1 clinical trial of Fesoterodine Oral Product in Urinary Incontinence, sponsored by Saint Thomas Health.

Who is sponsoring NCT00713921?

NCT00713921 is sponsored by Saint Thomas Health.

What drugs are being tested in NCT00713921?

Interventions in NCT00713921: Fesoterodine Oral Product.

What condition does NCT00713921 study?

NCT00713921 studies Urinary Incontinence, Bladder Dysfunction.

Is NCT00713921 still recruiting?

NCT00713921 is currently withdrawn. Last updated 11 September 2018.

Last reviewed 2018-09-11 · How we verify

NCT00713921

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients

Withdrawn EARLY_PHASE1 Last updated 11 September 2018

What this trial tests

EARLY_PHASE1 trial testing Fesoterodine Oral Product in Urinary Incontinence. Withdrawn.

Timeline

15 September 2009

Primary endpoint
17 January 2014

17 January 2014

Quick facts

Lead sponsor	Saint Thomas Health
Phase	EARLY_PHASE1
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Start date	15 September 2009
Primary completion	17 January 2014
Estimated completion	17 January 2014
Sites	1 location across United States

Drugs / interventions tested

Fesoterodine Oral Product — full drug profile →

Conditions studied

Urinary Incontinence — all drugs for Urinary Incontinence →
Bladder Dysfunction — all drugs for Bladder Dysfunction →

Sponsor

Saint Thomas Health — full company profile →

Who can join

Adults 21 to 85, female only, with Urinary Incontinence or Bladder Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Develop and quantify methods for evaluating bladder dysfunction in diabetes and stroke

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Urinary Incontinence

Currently open trials in the same condition.

NCT07430865 — The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation · NA · recruiting
NCT07105150 — Efficacy of a Video-Based Educational Program on Female Urinary Incontinence · NA · recruiting
NCT07426861 — Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence · NA · recruiting
NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting

Other Saint Thomas Health trials

Trials by the same sponsor.

NCT03257683 — RANOLAZINE STUDY: Speckle Tracking Derived Myocardial Strain · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00713921 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint Thomas Health
Last refreshed: 11 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00713921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing